snehalshaha
50+ Views

Ophthalmic Surgical Instruments Market to Expand at a Healthy Growth Rate in the Coming Years

The ophthalmic surgical instruments market is segmented into femtosecond lasers, excimer lasers, other lasers, and refractive surgery instruments & kits. The femtosecond lasers segment accounted for the major share of the refractive surgery devices market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment is attributed to its benefits such as lower incidence of dry eyes, less induced aberrations, greater safety, faster uncorrected visual acuity recovery, less intraocular pressure (IOP) variation in the femtosecond-created flap, and growing number of femtosecond laser-assisted surgeries being performed across the globe.

What the Market Looks Like?

The global Ophthalmic surgical instruments market is projected to reach USD 11.18 Billion by 2022 from USD 8.36 Billion in 2017, at a CAGR of 6.0%.
Based on product, the ophthalmology surgical instruments market is segmented into cataract surgery devices, vitreoretinal surgery devices, refractive surgery devices, glaucoma surgery devices, ophthalmic microscopes, and accessories. The cataract surgery devices segment accounted for the major share of the global ophthalmic surgical instruments market. The large share of this segment can primarily be attributed to the growing number of cataract surgeries across the globe. Glaucoma surgery devices segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the rising prevalence of glaucoma and technological advancements in the glaucoma surgical devices throughout the world.
What Drives the Market?
The growth of the global market for Ophthalmic Surgical Instruments is primarily influenced by the following factors:
· Rising Prevalence of Eye Diseases
· Technological Advancements in Ophthalmic Surgical Instruments
· Increasing Government Initiatives to Control Visual Impairment

North America accounted for the largest share of the ophthalmology surgical instruments market in 2016, followed by Europe. The large share of this region is attributed to rising prevalence of ocular disorders owing to growing geriatric population in North America, increase in healthcare expenditure, technological advancements in instruments & devices used for minimally invasive surgeries, and increasing regulatory approvals.
Top Key Players: -
The prominent players in the global ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).
Comment
Suggested
Recent
Cards you may also be interested in
Albumin & Creatinine Tests Market worth $2,103 million by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025", published by MarketsandMarkets™, the ACR Test Market is projected to reach USD 2,103 million by 2025 from USD 987 million in 2020, at a CAGR of 16.3%. Browse in-depth TOC on "Albumin and Creatinine Tests Market" 131 – Tables 32 – Figures 159 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568 The growth of the global albumin & creatinine tests market is driven by factors such as the growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019 Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth. Urine Tests segment to register the highest growth rate during the forecast period Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=156696568 North America is the largest regional market for albumin & creatinine tests market The global ACR Test Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share in the global market. The large share of this regional segment can primarily be attributed to the growth in demand for rapid urine tests, increasing prevalence of chronic conditions leading to various kidney diseases, rising government initiatives, and growing geriatric population. The major players operating in this ACR Tests Market are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc. (Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co., Ltd. (China). Browse Related Reports: Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html
Infusion Pump Software Market to witness major growth in coming years
Growth in the infusion pump software market is mainly driven by factors such as the increasing incidence of chronic diseases, along with rapid growth in the geriatric population, growing number of surgical procedures performed, rising demand for ambulatory and home care infusion pumps, and technological developments. The Infusion Pump Software Market is expected to reach USD 1,044 million by 2024 from USD 742 million in 2019, at a CAGR of 7.1%. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126400367 Market Segments:- On the basis of type, the infusion pump software market is segmented into Dose error reduction software (DERS), clinical workflow software, interoperability software and other software. The DERS segment held the largest share of the infusion pump software market in 2018 and this segment is also projected to register the highest growth during the forecast period. Increasing number of medication errors using infusion pumps is a major factor driving market growth. On the basis of indication, the market is segmented into general infusion, pain & anesthesia management, insulin infusion, chemotherapy, enteral infusion, and others. The general infusion segment commanded the largest share of the market in 2018. Recent Developments In March 2018, Baxter partnered with First Databank (FDB), US, with the aim of integrating FDB’s Infusion Knowledge, an evidence-based library of IV medications, into Baxter’s Dose IQ Safety Software to help make delivery of infusions safer. In August 2017, BS expanded in the US with the launch of BD Institute for Medication Management Excellence in New Jersey, which aims to improve patient safety and outcomes. In collaboration with national experts and IV safety organizations, this new institute would initially focus on enhancing end-to-end IV infusion Safety at the patient's bedside. Regional Analysis:- Geographically, North America is expected to dominate the global infusion pump software market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to growing incidences of chronic diseases, increased awareness and accessibility of advanced healthcare facilities, a large population pool, increasing aging population, and rising healthcare spending. Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=126400367 Top Key Players:- The major players operating in the infusion pump software market include BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), and Terumo Medical (Japan). Other players involved in this market include Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).
Preimplantation Genetic Testing Market Worth $ 541.8 Million by 2022- Exclusive Market Report by MarketsandMarkets™
According to a new market research report "Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) - Forecast to 2022", published by MarketsandMarkets™, the Global Preimplantation Genetic Testing Market is projected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%. Browse and in-depth TOC on " Preimplantation Genetic Testing Market 85 - Tables 42 - Figures 204- Pages Download PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=605 By application, the aneuploidy segment is expected to be the fastest growing segment in the forecast period The aneuploidy segment is expected to grow at the fastest CAGR. Growth of this segment can be attributed to the increasing maternal age, rising incidence of aneuploidy disorders, and strategic initiatives by key players to provide technologically advanced PGS products for aneuploidy screening. Aneuploidy screening has been reported to increase the chance of successful embryo implantation, decreases miscarriage rate, and reduce the chance of having a child with a chromosome abnormality). North America dominated the market in 2016 Geographically, the Preimplantation Genetic Testing Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe. Rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS), and increasing private-public funding to develop and commercialize novel PGS & PGD procedures are the key factors that account for the larger share of the Preimplantation Genetic Testing Market in North America. Talk To Our Research Analysts: -http://www.marketsandmarkets.com/speaktoanalyst.asp?id=605 As of 2016, the major product manufacturers operating in the global Preimplantation Genetic Testing Market included Illumina, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), and SciGene Corporation (U.S.), among others. Moreover, as of 2016, major service providers active in the global market included Beijing Genomics Institute (BGI) (China), Good Start Genetics (U.S.), CombiMatrix Corporation (U.S.), Genea Limited (Australia), Invicta Genetics (Poland), and Progenesis (U.S.).
3 Reasons Why Women Are Choosing Breast Augmentation With Fat Over Implants.
Autologous fat transfer, also known as fat grafting, has provided reconstructive and cosmetic plastic surgeons with a slew of new options. Fat transfer for breast augmentations, rather than traditional silicone or saline implants, has become one of the hottest trends in cosmetic plastic surgery. Because of the plethora of influencers and celebrities on social media, fat transfer breast augmentation is becoming increasingly popular. Patients are increasingly choosing fat grafting over more invasive breast augmentation surgeries for very simple, practical reasons. In this post, we'll go over the top three reasons why more women than ever before are opting for fat transfer breast augmentations. WHAT IS FAT GRAFTING EXACTLY? Fat grafting is a fascinating scientific procedure. To put it simply, fat grafting is the transfer of fat cells from areas of excess flab to areas where more volume is desired. The following are some examples of common fat grafting donor sites: Thighs Buttocks Belly Flankers (fat above your midsection on your back) Fat cells are typically used to accentuate the curvature of patients' breasts and buttocks during fat grafting procedures in cosmetic surgery. There are several advantages to using autologous fat transfer instead of breast implants if you want a small to medium increase in breast size or volume. In addition, some of the more recent fat transfer breast augmentation techniques include a pre-expansion technique that allows for larger increases in breast size. Breast Augmentation With Fat Can Solve Two Problems At Once. A fat transfer breast augmentation combines two of the most popular plastic surgery procedures performed each year: breast augmentation and liposuction. It's easy to see why most patients are ecstatic when we tell them we can make their breasts look better and melt away a little extra pudge in an area that makes them self-conscious. Almost everyone has stood in front of a mirror and pinched fat where they don't want it. With a fat transfer breast augmentation, your Cosmetic Surgeon can move a portion of your excess body fat to create beautiful curves in your breasts. You may be surprised at how much this can improve your self-esteem and make you feel great in (and out of) your clothes. Athletic Women Can Resume Workouts Sooner After Breast Augmentation With Fat. Breasts are mammary glands surrounded by body fat, and many athletic women choose breast augmentation to accentuate their feminine curves. This is because women who are extremely fit may lose a significant amount of body fat, which increases the volume of their breasts. Whether you're a competitive athlete or a fitness enthusiast, the recovery period that leaves you wanting to get back to exercising can be excruciating. The recovery time for fat transfer breast augmentation can be up to two-thirds faster than for traditional breast augmentation with implants. You Can Resume Office Sooner After Breast Augmentation With Fat. Accepting that how you look and feel about yourself has a significant impact on your success at work can be a difficult reality to accept. According to a study conducted by an economist at the University of Texas at Austin, a handsome man will earn nearly 15% more in his lifetime than someone who is not considered attractive. Professional considerations, like any other cosmetic procedure, can influence the decision to have breast augmentation. One of the main reasons our working professionals prefer breast augmentation with fat in Mumbai to implants is that it allows them to spend less time away from work while still achieving beautiful, natural-looking results. Patients who have implants must usually wait at least two weeks before returning to work, and sometimes even longer if their job requires physical exertion. Patients who opt for a fat transfer procedure are usually able to return to work within 4-5 days.
Infusion Pump Market worth $20.5 Billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)], Technology (Traditional, Specialty), Application (Cancer, Diabetes), & Setting (Hospital, Homecare) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 20.5 Billion by 2026 from an estimated USD 13.2 Billion in 2021, at a CAGR of 9.3%. Browse in-depth TOC on "Infusion Pump Market" 374 – Tables 81 – Figures 429 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 The Growth in the market is largely driven by the rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, growing number of surgical procedures performed, and increasing number of ICU beds in countries with a high prevalence of COVID-19. On the other hand, product recalls, stringent regulatory requirements for new products and increasing adoption of refurbished and rental infusion pumps are expected to restrain the overall market growth. Increasing incidence of medication errors and lack of wireless connectivity in most hospitals is the most common challenge faced by the market. High growth opportunities in emerging countries and growing adoption of specialty infusion systems are the opportunity areas in infusion pump market. The accessories & consumables segment holds the highest CAGR during the forecast period. The accessories & consumables segment is estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the recurrent use of accessories & consumables and the increasing adoption of infusion pumps for the delivery of medications in a controlled environment. Chemotherapy accounted for the highest share for the infusion pump market Based on application the chemotherapy/oncology application segment accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the growing incidence of cancer, increasing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products in the market. Home care settings drive the growth of the infusion pump market Based on setting, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic & research institutes. The home care setting segment accounted for the largest share of the market in 2020. Chronic diseases, such as cancer and diabetes, require continuous monitoring and treatment. Ambulatory infusion pumps for chronic disease management enable patients to remain mobile during therapy sessions. Therefore, the use of ambulatory insulin pumps in the home and alternate care segments has increased in the recent past. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=90374506 North America is expected to account for the highest share for players operating in the infusion pump market Geographically, the infusion pumps market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market, followed by Europe and the APAC. The large share of North America can primarily be attributed to the high adoption of specialty infusion pumps for the treatment of chronic diseases, increasing prevalence of chronic diseases, rising geriatric population, and the presence of many large hospitals in the region. Moreover, a large number of major global players are based in the US, owing to which the US is a center for innovation in the market. The infusion pumps market is dominated by Becton, Dickinson and Company (US), Baxter International Inc. (US), B. Braun (Germany), Smiths Medical (US), Fresenius Kabi (Germany), and ICU Medical, Inc. (US). These players adopted major growth strategies such as product launches & approvals, collaborations, and expansions. Other prominent players in the market include Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), Ypsomed Holding AG (Switzerland), InfuTronix Solutions LLC (US), SOOIL Development Co., Ltd (South Korea), Shenzhen MedRena Biotech Co., Ltd. (China), and CODAN Medizinische Geräte GmbH & Co KG (Germany). Browse Related Reports: Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024 https://www.marketsandmarkets.com/Market-Reports/infusion-pump-software-market-126400367.html Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021 https://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html
4 Factors of Influencer Marketing Changing The Digital Marketing View
At whatever point a business person produces a product, he/she needs to sell it. Since individuals will not accept the item that they don’t think about it, promotion is required. The technique for publicizing has changed throughout the long term. At first, there were handouts and notices in papers. At the point when TV turned out to be more accessible to individuals, makers changed towards T.V. to arrive at a more prominent number of times. Nonetheless, things weren’t so smooth. With a couple of dull ads and some different issues, individuals began losing trust in advertisements. Then, at that point, the publicists use superstars to advance their items. This strategy goes on today, yet it additionally faces comparable issues as in the past. As time passed by, individuals lost confidence in them also. Likewise, employing famous people was expensive, and now and then, it was simply not great. Regardless of whether big names have more than 100 million supporters, they can’t impact individuals. Their ad posts don’t create a lot of impacts as purchasers don’t believe famous people as they are frequently seen selling obscure items, which were demonstrated later to be misrepresentations for a buyer. Hence, publicists needed to consider something new. While attempting to comprehend the considered examples of purchasers, they understood that if an individual gets an item prescribed by somebody near him, say a family member, neighbor, or companion, the person may think, “Gee, possibly I should check it out.” Influencer MarketingNonetheless, it’s anything but feasible for promoters to disclose the general prescribed items to their nearby ones. Along these lines, they tracked down the ideal answer for abusing this mindset of customers, influencer marketing. Influencer Marketing includes individuals on the web who have a solid impact on individuals’ sentiments. They have a good number of followers on YouTube, Instagram, Twitter, and so forth With many individuals having the web nowadays, web-based media influencers have an extremely large reach. Considering the worth their assessments hold to their fans, it is defended to say that they are somebody near the overall population. Because of these reasons, publicists are utilizing online media influencers to advance and sell their items. Utilizing them, they develop a connection and trust between the customer and the producer. It has likewise gotten simpler to straightforwardly arrive at a particular objective crowd as opposed to elevating to a more summed up open which has permitted them to have a more noteworthy effect on them. This is a mutually beneficial arrangement for the two makers and influencers as the previous will sell their item, and the last gets some cash for advancing. There are a few factors sponsors look for in an influencer: 1: Large Influencer Marketing Followers Base: The makers need to elevate their items to countless individuals. Thus, they should search for influencers with a huge crowd, else the entirety of their cash will go to squander. followers that as it may, a decent crowd is something beyond numbers. Regardless of whether an influencer has 1,00,000+ supporters, be that as it may, their posts get a couple of thousand likes and snaps, then, at that point something is off-putting. Thus, as you are a publicist, you should see something beyond the devotee tally to choose if the influencer has an incredible adherent base and can persuade their supporters to purchase your item. On the off chance that you are an influencer and need to bring in cash by promoting the results of organizations, you should get countless faithful supporters so you can persuade organizations that you can have an effect on the promoter’s intended interest group. 2: Relevant to the interest: At whatever point a promoter needs to employ an influencer to promote his item, he needs to ensure that the influencer’s substance is relatable to what he is selling or promoting. On the off chance that you are a sponsor, you should know the sort of substance the influencer is making. You can sell your wellness item if the influencer’s primary substance depends on wellness, makeup if the influencer’s fundamental substance depends on the design, which doesn’t relate to your item. 3: The crowd should believe in influencers: The main thing in influencer showcasing is trust. Individuals will purchase the item if an influencer suggests it just in the event that they trust the influencer. In the event that you are a promoter and you need to decide if individuals trust the influencer, there are two things you can consider. First and foremost, the positive commitment of the influencer. You can check it by taking a gander at the posts made by them. Assuming there are positive remarks that appear to be real and not spam remarks, the person is a trusted influencer. For additional affirmation, you can likewise look at any bad remarks about that influencer. Secondly, you should check the number of perspectives in the recordings they post. Individuals take a gander at the substance of an influencer on the grounds that they like it. As time goes, trust in the influencer is constructed naturally. Accordingly, by taking a gander at the importance and perspectives on the substance of an influencer, you can decide if you can utilize the person in question to advance your items. 4: The influencers daily posting and active: On the off chance that an influencer is dynamic and posts routinely, their fanbase gets consistent development. As a sponsor, you should guarantee that the influencers you need to utilize should post consistently. Telling the customer about the item and its great impacts routinely can persuade them to purchase the item and check it out. Additionally, ordinary action by the influencers will mean development in your intended interest group. Final Thoughts: Influencers showcasing has changed the promoting game radically, and it’s anything but a beneficial outcome on both the publicist, influencer. As more customers invest energy on their web-based media than on TVs, they become acquainted with a huge assortment of items out there. Influencer Marketing is changing the way of marketing in a better and more efficient way to reach particularly interested audiences and helps in decreasing advertising budgets. Call Bharat – Digital Marketing Services in Hyderabad is a leading Digital Marketing company that deals in all various types of Digital Marketing Services and also deals in influencer marketing. We can help you out in reaching your best product influencers and get you more accurate results.
What Impacted COVID-19 on Surgical Visualization Products ?
COVID-19 Impact on Surgical Visualization Products in Healthcare Industry The first case of the COVID-19 pandemic was found in Wuhan, China. This pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. The COVID-19 spread worldwide in unprecedented ways due to its high infectious and contagious nature and lack of availability of its vaccine. As a result, the greatest medical challenge in the 21st century is yet to be faced by physicians worldwide. Though the emergence of the virus can be traced back to Asia, many European countries and the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. The COVID-19 has been declared as a pandemic by WHO due to its increased spread across the globe. Various countries announced complete lockdown just after the declaration of COVID-19 as a pandemic, such as the U.S., India, Germany, and China, to protect them from spreading the disease. According to the weekly epidemiological report of 23rd August 2020 by WHO, a cumulative total of 23 million cases of Coronavirus have been reported globally, and 800,000 patients are dead due to the Coronavirus. Surgical visualization products are used to improve the quality of images of internal organs with greater resolution. They improve the surgical process and enhance communication between healthcare professionals, specialty clinics, and patients. 3D visualization technology’s incorporation in diagnostics has enabled easy inspection and visualization of organs in 360 views, thereby being the accurate and improved quality of surgery. Surgeons and healthcare professionals widely prefer surgical visualization to evaluate, inspect and treat internal organs from a distance from the target organs without incision. The rise in chronic diseases, advancement in surgical visualization, rising healthcare expenditure are acting as drivers for the global surgical visualization products market. The implications of COVID-19 have considerable influence on the surgical visualization products market. Various factors that indirectly influence the decline in medical surgery procedures include flight cancellations, travel bans, mass quarantine, growing panic among the population, and uncertainty about the future. IMPACT ON PRICE Delay associated with various types of limitations due to the pandemic faced by the manufacturers to fulfill the end product order, which has resulted in less availability of surgery devices in the market. The cost of available devices has increased with several factors. Also, due to the Coronavirus disease (COVID-19) pandemic, manufacturers are forced to find new contract manufacturers and suppliers to move manufacturing activities to different or new facility locations less impacted by the outbreak. If the COVID-19 continues to spread for prolonged period, then it is estimated that the demand for surgery devices will downgrade by top importer countries. Moreover, top surgical visualization product importers' countries such as the United States and Europe are primarily concentrating on dealing with Coronavirus (COVID-19); due to this reason, demand for these surgical visualization products are decreased from the United States followed by Italy. In current situations, the manufactures of surgical visualization products are facing difficulties with the existing component supplier or contract, manufacturers who are at risk or closed or not being able to fulfill supply requirements, due to challenges such as extended periods of shut down or workforce are responsible for price fluctuation of surgical visualization products. IMPACT ON DEMAND Coronavirus disease (COVID-19) is an infectious disease caused by a SARS-CoV-2 virus, while a large population is affected by this COVID-19 virus. Coronavirus disease (COVID-19) causes acute respiratory illness ranges from mild to severe pneumonia with respiratory failure. Nearly all the countries have taken initiative action under locked down and social distancing restrictions to minimize the spread of COVID-19. Sudden shrink took place in various surgeries due to affirmative restrictions. Reduction in surgeries across the globe is adversely affecting the on-demand of minimally invasive surgery devices. However, due to lockdown and social distancing restrictions, most of the patient pool prefers virtual visits through video calling or telehealth video visiting. In compliance with the Centers for Disease Control recommendations, the American College of Surgeons, the Brazilian Society of Plastic Surgery, and the American Society of Plastic Surgeons recommended postponing or canceling elective surgery. The goal of this recommendation is two-fold: first to minimize patient and visitor traffic in healthcare settings to reduce transmission between patients and healthcare workers and secondly, to preserve essential resources, especially hospital beds, critical care and ventilator supplies, and PPE critical to the safety of patients and healthcare professionals. Moreover, the decrease in the revenue of the key market players depicted in their quarterly results, such as Johnson & Johnson Services, Inc., among others, gave evidence of the decline in the demand for medical devices due to the emergence of the COVID-19 pandemic. For instance, · Johnson & Johnson Services, Inc., reported a decline of 10.5% in its medical devices net sales of the fourth quarter of 2020 compared to 2019. The reduction was largely motivated by the detrimental effects of the COVID-19 pandemic and the subsequent deferral to companies of medical procedures. IMPACT ON SUPPLY The COVID-19 pandemic has transformed various organizations’ business environments; supply availability has been hampered by many issues, including export and travel restrictions by some producing countries and lockdowns that have forced suppliers to (temporarily) shut down. Healthcare organizations have been firmly monitoring the supply chain with the assumption that the COVID-19 outbreak may adversely impact the supply chain of medical devices, including shortages of surgical visualization products or potential disruptions in its supply chains to minimize supply chain crises. For instance, · The Zimmer Biomet spine, dental and CMFT segment sales have a decrease of 10.3% and found a decline in total sales from USD 1,161.3 million in 2019 to USD 1,043.7 million in 2019. These decline in sales are due to disruption of the supply chain and change in the focus to COVID 19 Several organizations are looking forward to improving and diversifying supply chain models to manage such a crucial situation. A diversified supply chain model anticipated minimizing the export of medical devices and increasing end-to-end visibility. The resulting COVID-19 pandemic has shown the various ways for supply chain management, which may be effective within a remote working environment. STRATEGIC DECISIONS BY MANUFACTURERS A large pool of population affected by COVID-19 virus and spread been expanding across the world in the last few months. Various market players are creating new strategies to deal with the COVID-19 outbreak challenges. The companies are now opting for digital media such as telecommunication, mobile applications, webinars, and other digital media to support the patient required to tackle the pandemic situation and increase their revenue and growth. Moreover, to accomplish the market demand, small market players are utilizing the partnership agreement strategy. It is projected that these strategies are anticipated to escalate up the company revenue and its growth in the forecast period. For instance, · In September 2021, Smith & Nephew launched LENS 4K surgical imaging system, a state-of-the-art visualization platform designed for end-to-end 4K imaging, which has created a persistent revenue-generating path for the company. · In January 2016, CONMED Corporation completed the acquisition of privately-held SurgiQuest, Inc. This acquisition has strengthened company’s leadership in the market. Furthermore, for the economic recovery after the pandemic of COVID-19, the manufacturers of surgical visualization products have to adopt several types of strategic initiatives in terms of increasing R&D activities conduct numerous types of market surveys to know the current situation and mindset of consumers towards their need. The increasing R&D activities will help the manufacturers to launch the advanced equipment by knowing the advanced technology or need of the end user. CONCLUSION The market is expected to decline due to increased restrictions imposed by various governments leading to the closing of non-emergent healthcare facilities, including procedures such as surgery medical devices. The mass quarantined imposed by the government put a stop to transportation, international travel, among others which reduced the chances of such surgery. The market player has experienced decreasing customer demand for its products beginning in the second half of its first quarter of 2020. Thus, the COVID-19 pandemic has an adverse impact on the market, affecting the price, supply, and demand of surgical visualization products. However, in the crisis call, market players, government bodies, and healthcare organizations are working closely with healthcare professionals, customers, and patients to better public health. However, companies and government bodies exclusively concentrate on making the most effective and best contribution to control the spread of the virus and save lives. They are also ramping up the production of essential medication to a new level and ensuring that speed doesn’t affect or destroy the quality of products.
mHealth Solutions Market worth $213.6 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "mHealth Solutions Market by Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter, Pulse Oximeter), Apps (Weight Loss, Women Health, Diabetes Management, Mental Health), Services (Remote Monitoring, Consultation) - Global Forecast to 2025",is projected to reach USD 213.6 billion by 2025 from USD 50.8 billion in 2020, at a CAGR of 33.3 % during the forecast period. The growing adoption of smartphones, increasing penetration of 3G/4G networks, rising focus on cost containment in healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the growth of this market. Browse in-depth TOC on " mHealth Solutions Market 303 -Tables 43- Figures 291- Pages Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232 The mHealth apps segment accounted for the largest share of the mHealth solutions market in 2019 Based on product and service, the mHealth apps segment accounted for the largest share of the mHealth solutions market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and healthcare apps and the rising incidence of chronic and lifestyle-related diseases across the globe (coupled with the effective utilization of apps in chronic disease management). Based on region, North America accounted for the largest share of the mHealth solutions market in 2019 Based on region , the mHealth solutions market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019. This is due to the increasing penetration of smartphones, rising prevalence of chronic and lifestyle disorders, increasing healthcare costs, increasing demand for better healthcare services, government initiatives to promote digital health, robust penetration of 3G and 4G networks, and the rising awareness of self-health management. Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=1232 The prominent players in this market are Medtronic plc (Ireland), Apple, Inc. (US), AirStrip Technologies (US), AliveCor, Inc. (US), Nike, Inc. (US), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Omron Corporation (Japan), BioTelemetry, Inc. (US), athenahealth, Inc. (US), AgaMatrix, Inc. (US), Withings S.A. (France), and iHealth Labs, Inc. (US).
Urinary Catheters Market worth $2.6 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) & Region - Global Forecast To 2025", published by MarketsandMarkets™, the global Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Browse in-depth TOC on "Urinary Catheters Market 125 – Tables 35 – Figures 165 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market. In 2019, the indwelling catheters segment accounted for the largest share of the urinary catheters market Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market. The coated catheter segment is expected to grow at the highest CAGR during the forecast period By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction. North America was the largest regional market for urinary catheters market in 2019 The market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132934629 The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India). Browse Related Reports: Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/catheters-market-6247803.html
9 Effective Skincare Tips For Teenagers With Acne
A pimple develops when the pores of the skin become clogged with sebum; a type of oil that normally lubricates the skin and hair. Acne is common during puberty, when hormones kick in and the skin produces an abnormally high amount of sebum. Because the forehead, nose, and chin contain so many oil-producing glands, this area, dubbed the T-zone, is the most prone to pimples. Here are a few pointers to help you avoid and treat breakouts quickly: Wash your face twice daily with warm water and a gentle acne-specific cleanser (no more). Massage your face gently in circular motions. No scrubbing is required. Excessive washing and scrubbing can irritate the skin. After cleansing, apply a low-strength benzoyl peroxide lotion. Never squeeze your pimples. It's tempting, but here are some reasons why you should avoid it: Pimple popping can result in the push of infected material deeper into the skin, causing swelling, redness, and acne scarring. If you notice a pimple developing prior to a significant event, such as a wedding, a dermatologist can frequently treat it with minimal scarring or infection. Don't touch your face or lean your face against objects that collect sebum and skin residue, such as your phone. By touching your face, you can spread bacteria and cause inflamed and irritated pores. Wash your hands before applying anything to your face, such as your acne treatment creams or makeup, to keep bacteria at bay. Clean your pair of glasses or sunglasses to avoid clogging the pores around your eyes and nose with oil. Avoid tight fitting clothes if you have acne on your body. They obstruct the skin's ability to breathe and may irritate it. On scarves, headbands, and caps, dirt and oil can also accumulate. Remove your makeup before going to bed. When shopping for makeup, look for brands that list "non-comedogenic" or "non-acnegenic" on the label. Remove any old makeup that has a different smell or appearance than the day you purchased it. Keep your hair clean and away from your face to avoid clogging your pores with dirt and oil. Never skip sunscreen. While a tan may appear to conceal acne, this is only temporary. A tan may aggravate your acne rather than help it. Additionally, tanning wreaks havoc on the skin, causing wrinkles and increasing your risk of developing skin cancer. Consult a dermatologist if you are concerned about acne. Dermatologists offer a variety of acne treatment options for acne scar prevention and treatment. A dermatologist can assist you in determining the most effective treatment method for you and provide you with a wealth of useful advice on how to manage acne and care for your particular skin type.
Hyaluronic Acid - The Natural Skin Plumping Sugar
Despite its tough pronunciation and even more complicated spelling; hyaluronic acid is an important part of your daily skin care routine. It's widely used in serums, sheet masks, and moisturisers. This is because HA, a naturally occurring molecule in the skin, binds to water and plumps the face, giving it a dewy, glowing appearance. It's clear that word of its benefits has spread, as it's one of the most sought-after ingredients in skin-care products. Aside from increasing skin moisture levels, hyaluronic acid serves other functions. What is hyaluronic acid, exactly? Hyaluronic acid is a naturally occurring sugar molecule in the skin that helps water bind to collagen, keeping it in place and giving the skin a plumper, dewier, and more hydrated appearance. Essentially, hyaluronic acid improves skin hydration, which helps to maintain the skin's youthful, full, and bouncy appearance. Collagen in our dermis determines the structure of our skin. Natural hyaluronic acid is covalently linked to water molecules on one side and collagen on the other, providing plumpness to the skin. What is hyaluronic acid's function? As we age, our collagen and hyaluronic acid levels gradually decline, causing our skin to become increasingly dry. Furthermore, winter heaters, specific skin care products, and underlying skin disorders can cause microscopic tears in the protective skin barrier, allowing water to escape. As a result, implementing a customised skin care regimen that includes moisturising products could be extremely beneficial. Hyaluronic acid, glycerin, colloidal oatmeal, urea, propylene glycol, and sorbitol are humectants, which draw water to the skin to hydrate it. These chemicals can be found in a variety of products, such as moisturisers, eye creams, and serums. The use of HA-containing products tightens the skin around the eyes, increases moisture to reduce puffiness, and softens fine wrinkles throughout the face. Hyaluronic acid is effective when applied topically due to its ease of penetration. Our skin is the largest organ in the body, soaking up up to 60% of the nutrients applied to it. Furthermore, the lightweight, fluid nature of hyaluronic acid, as well as its ability to retain moisture from the environment and deeper dermis to completely hydrate the skin, are benefits. Who should benefit from hyaluronic acid? All skin types benefit from hyaluronic acid. It is non-irritating in general and does not aggravate acne, rosacea, or allergic skin conditions. However, there is a very small chance of experiencing any negative consequences. Individuals with dry and/or older skin will benefit the most from the application of hyaluronic acid. Because our bodies produce less hyaluronic acid as we age, people in their forties and fifties will benefit the most from applying it topically. Despite the fact that the term "acid" appears in the term of hyaluronic acid, those with sensitive skin should not be worried; it is completely safe for everyone. Because hyaluronic acid is naturally produced in our bodies, there are no known side effects from using it. If you have an allergic reaction to it or a product that contains it, contact your dermatologist immediately; the reaction could be caused by another active or inactive ingredient. Injectable Hyaluronic Acid Injections of hyaluronic acid are also available. Hyaluronic acid is a gel-like substance found in dermal fillers that attracts water after injection to replenish volume and restore lost structure. This helps to smooth the appearance of lines and wrinkles while also reducing the overall sunken or drooping appearance of the face. These dermal fillers can be used to treat nasolabial folds, marionette lines, cheek augmentation, chin augmentation, undereyes, lips, and back of the hands, among other things. Because the quality of fillers varies, it's critical to consult with your dermatologist about your options to ensure you get the best one for you. A cosmetic surgeon compares different types of hyaluronic acid fillers to different types of paintbrushes. They all contain the same component, but the density, lift-ability, and durability of the molecules vary depending on their size and arrangement. Additionally, it is reversible. Because it is injected into your face, it is not permanent. Because hyaluronic acid dermal fillers are reversible, your dermatologist can dissolve the filler quickly using the enzyme hyaluronidase if you are dissatisfied with the results or if a blood artery is blocked during the injection process. The enzyme works quickly; the substance dissolves quickly and is completely destroyed within 24 to 48 hours. Individuals who are allergic to bees, on the other hand, should proceed with caution — and consult a dermatologist — before attempting hyaluronidase-based therapy because the enzyme is found in bee venom. Hyaluronic acid fillers, on the other hand, are not for everyone. Except for pregnant women, the vast majority of people can benefit from hyaluronic acid fillers. Pregnancy and fillers have not been thoroughly studied, but dermatologists generally avoid injecting pregnant women due to uncertainty. Furthermore, if you have a current skin infection, you should avoid these fillers. First, treat the infection, and then return to your appointment once your dermatologist has given you the all-clear. If you're thinking about using hyaluronic fillers, there are a few minor risks to be aware of. Bruising and swelling are the most common side effects of any injectable treatment. The good news is that these shortfalls will only last a short time. Tenderness should subside within a few days. To reduce the risk of bruising, blood-thinning medications such as aspirin, ibuprofen, and red wine should be avoided for about a week before treatment. Furthermore, arnica and bromelain may aid in the reduction of swelling and bruising.
The Growth of Cell and Gene Therapies Relies on a Strong Foundation and the Perfect Location
The global cell gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7 billion in 2021, at a CAGR of 12.4% during the forecast period. Growth in cell gene therapy manufacturing services market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical RD, investments in advanced technologies by CDMOs, and increasing partnerships agreements between pharmaceutical companies and CDMOs. However, the high operational costs associated with cell gene therapy manufacturing are expected to restrain the growth of cell gene therapy manufacturing services market to a certain extent.  The pandemic slowed the economic growth of various countries, including the US, Germany, the UK, India, and China. It also resulted in control measures that impacted operations in life science organizations, such as production and research. In an article published by Nature Biotechnology, the CEO of Flagship Pioneering (US) stated that lab productivity at many of its research-based setups was running at just 30–50% capacity, and even upholding that rate was a challenge. According to GEP Worldwide, more than 1,200 clinical trials across the globe were disrupted by June 2020. Nearly 61% of clinical trials were disrupted due to the suspension of patient enrolment. The impact varied due to changes in COVID-19 case volumes throughout the year, but the worst effect was seen in April 2020. Trials involving respiratory disease, oncology, ID/anti-infectives, and cardiovascular disease were the worst-hit during this time. Most pharmaceutical companies continue to invest heavily in the development of novel drugs and devices. The pharmaceutical industry, in particular, is RD-intensive. Pharmaceutical companies invest in RD to deliver high-quality and innovative products to the market.  Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=180609441 The trend suggests that the top pharma companies are increasing their RD efficiencies through heavy RD investments to see returns on their investment in the long run and through collaborative RD efforts. According to an EvaluatePharma report, the worldwide pharmaceutical RD spending was valued at USD 136 billion in 2012; this increased to USD 186 billion in 2019. With the impact of COVID-19, the global pharma RD growth rate has dropped to 0.3% from 2019–2020.  As per report findings, this RD spend is expected to grow steadily between 2019 and 2026 at a CAGR of 3.2% to reach USD 232.5 billion, slower than the historical CAGR of 4.6% between 2012 and 2019. The increase in pharmaceutical RD has resulted in a sharp increase in the number of cell gene therapy candidates under development. This has made it necessary to outsource manufacturing services to develop cost-effective and efficient cell gene therapies.  Currently, there are 1,200 cell gene therapies in trials worldwide. There are more than 700 investigational cell gene therapies in clinical development in the US alone. However, manufacturing facilities have not kept up. It has been estimated that hundreds of facilities will be needed to manufacture the treatments that are now in clinical trials. One of the areas that need to be accelerated is viral capacity.  Most viral vectors are produced using adherent manufacturing, which is expensive to operate—a vial of 20 million cells can cost USD 20,000 to USD 30,000 to make. The cost of manufacturing for gene therapy can be between USD 500,000 and USD 1 million, excluding the costs for RD, the costs to run crucial clinical trials, or the costs to build the commercial infrastructure necessary to provide access to patients.  Download PDF Brochure With Latest Edition @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180609441 According to a 2020 PhRMA report on the cell gene therapy pipeline in 2018, there were 289 cell gene therapies in clinical development by biopharmaceutical companies. This number increased by 25% in 2020, with 362 cell gene therapies in clinical development. In addition to this, according to data released by CGT Catapult, there were 154 ATMP clinical trials ongoing in the UK in 2020 compared to the 127 trials reported in 2019, indicating an increase of more than 20%.  This significant growth in the number of cell gene therapy clinical trials is expected to drive the demand for manufacturing services and, in turn, propel growth in the cell gene therapy manufacturing services market.  This can primarily be attributed to factors such as increasing awareness about cell therapy, growing funding for new cell lines, increasing partnerships and acquisitions, and the development of advanced genomics methods for cell analysis.  Key Market Players Key players in the cell gene therapy manufacturing services market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Charles River Laboratories (US), Lonza (Switzerland), Catalent (US), WuXi AppTec (China), Takara Bio Inc. (Japan), Nikon Corporation (Japan), FUJIFILM Holdings Corporation (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), Oxford Biomedica plc (UK), and Cell and Gene Therapy Catapult (UK).
Increased Adoption of Refurbished Diagnostic Imaging Systems - Fluoroscopy Equipment
The market for fluoroscopy equipment is expected to grow from USD 5.9 billion in 2020 to USD 7.5 billion by 2025, at a CAGR of 4.8% during the forecast period. Growth in the fluoroscopy equipment market is attributed to factors such as the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, the rising geriatric population, and the growing prevalence of chronic diseases.  The COVID-19 pandemic has significantly impacted the buying capacity of hospitals, especially small-scale hospitals and scanning centers. According to an article in Livemint, private hospitals in India have faced revenue losses of up to 90% due to the COVID-19 pandemic. The pandemic has also impacted the operation of manufacturing companies.  The evolution of fluoroscopy systems and C-arms from traditional X-ray image intensifier technology to digital flat-panel detectors (FPDs) has brought about significant advancements in fluoroscopic imaging. FPDs have a number of advantages over image intensifiers, including compact sizes and reduced radiation dose. Systems with FPDs have the potential for higher image resolution than their predecessors.  FPDs offers no image distortion, greater sensitivity, and better patient coverage. Due to their advantages, many hospitals are now opting for FPD fluoroscopes. The growing preference for advanced technologies, and the need to shift to new, more efficient products, will be a key factors driving the growth of this market segment.  Download PDF Brochure With Latest Edition @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341 Fluoroscopic procedures can result in high radiation dose exposure for complex procedures, such as stent placement. These procedures are time-consuming, which greatly increases the radiation that patients are exposed to and the risk of hazards such as radiation-induced injuries to the skin and underlying tissues. The long-term side-effects of prolonged radiation exposure can also include cancer. This has served to push users towards non-radiation modalities, particularly in the case of pediatric patients. For instance, the ACR (American College of Radiology) Appropriateness Criteria specify that for infants younger than two months, ultrasound should be considered before a fluoroscopic examination. Additionally, CT examinations can completely eliminate the need for a fluoroscopic examination, as a CT scan is noninvasive as opposed to minimally invasive fluoroscopic imaging.  Many hospitals in developing countries are unable to invest in fluoroscopy equipment due to their high costs, poor reimbursement rates, and budget constraints, and therefore prefer refurbished systems. These systems are less expensive than new systems—approximately 40% to 60% of the original price. Increasing demand for refurbished devices poses a major challenge to the sales of new instruments—and, subsequently, to the growth of market players and small manufacturers. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=23056341 These systems come with a software package that helps store patient information. With the help of data integration, physicians can easily compare scans to effectively observe disease progression. To devise a treatment plan, clinicians are demanding access to integrated, comprehensive data on the patient’s diagnostic history. In addition to data integration, there lies a huge opportunity for making data available through mobile technologies. This will help doctors to view and study scans wherever they are. Due to their advantages, convenience, and huge demand from clinicians, data integrated systems offer a huge opportunity for market growth. The rising prevalence of cardiovascular diseases and the increasing number of orthopedic surgeries are some of the major factors driving the growth of the mobile C-arms market. C-arms are used for a wide range of applications, including surgeries for cardiovascular diseases, neurosurgeries, and surgeries for gastroenterology, orthopedics, traumatology, and urology disorders. Cardiology is the largest diagnostic application segment of the fluoroscopy equipment market. The large share of this segment is attributed to the high burden of cardiovascular diseases (CVDs) worldwide and the convenience and better results offered by fluoroscopy systems during the diagnosis and treatment of various cardiac disorders. Key Market Players The major players in the fluoroscopy equipment market are Siemens Healthineers (Germany), GE Healthcare (US), and Philips (Netherlands). These companies together accounted for a share of ~80% of the fluoroscopy equipment market in 2018. Other players in the market include Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and ADANI Systems Inc. (Belarus) among others.
Animal Treatment: High Country Humane looking ahead to 2024
The growth of the animal treatment market can be attributed to increasing government initiatives, which ensure maximum preventive healthcare in animals. A majority of the developed economies have norms that impel owners to have pet insurance.  On the basis of animal type, the animal treatment market is segmented into dogs, cats, pigs, poultry, cattle, and horses. The poultry segment will receive maximum veterinary care in the coming years. Earlier, the health of poultry was neglected to a greater extent. Chickens having underlying conditions were discarded without providing any veterinary treatment. However, with various animal cruelty acts in place, the mortality rate in poultry has decreased.   Download PDF Brochure With Latest Edition @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180479252 Based on the type of treatment, the animal treatment market is segmented into no medicalization, basic medicalization, and veterinary care. There has been a considerable decline in the percentage of animals receiving no medicalization, due to the rising awareness regarding the availability of reimbursement for veterinary services. As a result, owners have started prioritizing the health of their companion animals.  The number of dogs and cats receiving vaccination and treatment in these countries has increased. This trend is projected to continue until the end of 2024. Furthermore, in the case of livestock, animal welfare authorities have assigned diligent veterinarians for farms to assure maximum preventive healthcare. North America is the largest market in terms of the consumption of veterinary products. People are well versed with animal healthcare regulations, and hence high-quality care is provided to animals in this region. However, the animal treatment market has become saturated in the US, as the number of veterinary visits has stabilized. On the contrary, the animal treatment rate in European countries has increased. The increasing standard of living and the growing number of veterinarians providing exceptional medical services to animals are the major factors driving the European animal treatment market. Prominent players in the animal treatment market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Abaxis (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation (US).